Last updated: 2026-09-07 20:44:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
FibroGen, Inc. (FGEN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
FibroGen, Inc. (FGEN) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, FGEN traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, FibroGen, Inc. (FGEN) moved from $8,76 to $9,71, representing a gain of 10,84% ($0,95).
The stock traded between $8,50 and $9,75 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 27,10 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 225 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of FibroGen, Inc. (FGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.